Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 7869095, 7 pages
http://dx.doi.org/10.1155/2016/7869095
Research Article

Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer

1Laboratory of Molecular and Cellular Biology, Faculty of Natural and Life Sciences, Mentouri Brothers University, Constantine, Algeria
2Medical Oncology Department, EH Didouche Mourad, Constantine, Algeria
3Faculty of Medicine, University of Constantine 3, Constantine, Algeria
4Medical Oncology Department, Anti-Cancer Center of Setif, Setif, Algeria
5Department of Medical Genetics, Montpellier Regional University Hospital Center, Montpellier, France

Received 30 September 2015; Accepted 26 January 2016

Academic Editor: Lance A. Liotta

Copyright © 2016 Sarra Henouda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012, International Agency for Research on Cancer, World Health Organization, 2012.
  2. F. Cherbal, R. Bakour, S. Adane, K. Boualga, G. Benais-Pont, and P. Maillet, “BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families,” Disease Markers, vol. 28, no. 6, pp. 377–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Wooster, G. Bignell, J. Lancaster et al., “Identification of the breast cancer susceptibility gene BRCA2,” Nature, vol. 378, no. 6559, pp. 789–792, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Miki, J. Swensen, D. Shattuck-Eidens et al., “A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1,” Science, vol. 266, no. 5182, pp. 66–71, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Ford, D. F. Easton, M. Stratton et al., “Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families,” The American Journal of Human Genetics, vol. 62, no. 3, pp. 676–689, 1998. View at Publisher · View at Google Scholar
  6. A. Antoniou, P. D. P. Pharoah, S. Narod et al., “Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies,” American Journal of Human Genetics, vol. 72, no. 5, pp. 1117–1130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. E. B. Claus, N. Risch, and W. D. Thompson, “Genetic analysis of breast cancer in the cancer and steroid hormone study,” The American Journal of Human Genetics, vol. 48, no. 2, pp. 232–242, 1991. View at Google Scholar · View at Scopus
  8. T. S. Frank, A. M. Deffenbaugh, J. E. Reid et al., “Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals,” Journal of Clinical Oncology, vol. 20, no. 6, pp. 1480–1490, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. T. S. Frank, S. A. Manley, O. I. Olopade et al., “Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk,” Journal of Clinical Oncology, vol. 16, no. 7, pp. 2417–2425, 1998. View at Google Scholar · View at Scopus
  10. BRACAnalysis® Technical Specifications Myriad Genetic Laboratories, April 2013, https://s3.amazonaws.com/myriad-library/technical-specifications/BRCA+Tech+Specs_Integrated.pdf.
  11. T. Judkins, E. Rosenthal, C. Arnell et al., “Clinical significance of large rearrangements in BRCA1 and BRCA2,” Cancer, vol. 118, no. 21, pp. 5210–5216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Beaudet and L.-C. Tsui, “A suggested nomenclature for designating mutations,” Human Mutation, vol. 2, no. 4, pp. 245–248, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. Fackenthal and O. I. Olopade, “Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations,” Nature Reviews Cancer, vol. 7, no. 12, pp. 937–948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Troudi, N. Uhrhammer, C. Sibille et al., “Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia,” Journal of Human Genetics, vol. 52, no. 11, pp. 915–920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Tazzite, H. Jouhadi, S. Nadifi et al., “BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants,” Gynecologic Oncology, vol. 125, no. 3, pp. 687–692, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Uhrhammer, A. Abdelouahab, L. Lafarge, V. Feille, A. B. Dib, and Y.-J. Bignon, “BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases,” International Journal of Medical Sciences, vol. 5, no. 4, pp. 197–202, 2008. View at Google Scholar · View at Scopus
  17. A. Laraqui, N. Uhrhammer, I. Lahlou-Amine et al., “Mutation screening of the BRCA1 Gene in early onset and familial breast/ovarian cancer in Moroccan population,” International Journal of Medical Sciences, vol. 10, no. 1, pp. 60–67, 2013. View at Publisher · View at Google Scholar
  18. L. Perrin-Vidoz, O. M. Sinilnikova, D. Stoppa-Lyonnet, G. M. Lenoir, and S. Mazoyer, “The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons,” Human Molecular Genetics, vol. 11, no. 23, pp. 2805–2814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. C. Antoniou and D. F. Easton, “Models of genetic susceptibility to breast cancer,” Oncogene, vol. 25, no. 43, pp. 5898–5905, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. W. van den Ouweland, W. N. M. Dinjens, L. C. J. Dorssers et al., “Deletion of exons 1a-2 of BRCA1: a rather frequent pathogenic abnormality,” Genetic Testing and Molecular Biomarkers, vol. 13, no. 3, pp. 399–406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-C. King, J. H. Marks, and J. B. Mandell, “Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2,” Science, vol. 302, no. 5645, pp. 643–646, 2003. View at Publisher · View at Google Scholar
  22. S. A. Narod, “Modifiers of risk of hereditary breast cancer,” Oncogene, vol. 25, no. 43, pp. 5832–5836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Bergman, A. Flodin, Y. Engwall et al., “A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques,” Familial Cancer, vol. 4, no. 2, pp. 89–96, 2005. View at Publisher · View at Google Scholar
  24. T. Donenberg, J. Lunn, D. Curling et al., “A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas,” Breast Cancer Research and Treatment, vol. 125, no. 2, pp. 591–596, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. W. D. Foulkes, I. M. Stefansson, P. O. Chappuis et al., “Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer,” Journal of the National Cancer Institute, vol. 95, no. 19, pp. 1482–1485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. R. Lakhani, M. J. Van De Vijver, J. Jacquemier et al., “The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2,” Journal of Clinical Oncology, vol. 20, no. 9, pp. 2310–2318, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Palacios, E. Honrado, A. Osorio et al., “Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers,” Breast Cancer Research and Treatment, vol. 90, no. 1, pp. 5–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Anglian Breast Cancer Study Group, “Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases,” British Journal of Cancer, vol. 83, no. 10, pp. 1301–1308, 2000. View at Publisher · View at Google Scholar
  29. M. Rohani-Rasaf, M. Abdollahi, S. H. Jazayeri, N. Kalantari, and M. Asadi-Lari, “Correlation of cancer incidence with diet, smoking and socio-economic position across 22 districts of Tehran in 2008,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 1–3, pp. 1669–1676, 2013. View at Google Scholar